Portfolio

Atriva

Atriva Therapeutics stands for the next generation of antiviral therapies. MEK Inhibitors have high potential as truly efficacious and safe antiviral drugs to address the urgent need e.g. for a novel, broadly active influenza therapy.

Info & Contact

Address

Atriva Therapeutics GmbH
Christophstr. 32
D-72072 Tübingen

In portfolio

27. Dec 2016